Protein interaction switches coordinate Raf-1 and MST2/Hippo signalling

Signal transduction requires the coordination of activities between different pathways. In mammalian cells, Raf-1 regulates the MST–LATS and MEK–ERK pathways. We found that a complex circuitry of competing protein interactions coordinates the crosstalk between the ERK and MST pathways. Combining mathematical modelling and experimental validation we show that competing protein interactions can cause steep signalling switches through phosphorylation-induced changes in binding affinities. These include Akt phosphorylation of MST2 and a feedback phosphorylation of Raf-1 Ser 259 by LATS1, which enables Raf-1 to suppress both MST2 and MEK signalling. Mutation of Raf-1 Ser 259 stimulates both pathways, simultaneously driving apoptosis and proliferation, whereas concomitant MST2 downregulation switches signalling to cell proliferation, transformation and survival. Thus, competing protein interactions provide a versatile regulatory mechanism for signal distribution through the dynamic integration of graded signals into switch-like responses.

[1]  R. Linding,et al.  Simplistic pathways or complex networks? , 2010, Current opinion in genetics & development.

[2]  Jing Chen,et al.  Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK–ERK independent mechanism , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  W. Kolch,et al.  A Raf-1 Mutant That Dissociates MEK/Extracellular Signal-Regulated Kinase Activation from Malignant Transformation and Differentiation but Not Proliferation , 2003, Molecular and Cellular Biology.

[4]  A. King,et al.  Phosphorylation of Raf-1 serine 338-serine 339 is an essential regulatory event for Ras-dependent activation and biological signaling , 1997, Molecular and cellular biology.

[5]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[6]  Gabriele Gillessen-Kaesbach,et al.  Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation , 2010, Human mutation.

[7]  C. Marshall,et al.  Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation , 1995, Cell.

[8]  Richard Marais,et al.  The RAF proteins take centre stage , 2004, Nature Reviews Molecular Cell Biology.

[9]  G. Pfeifer,et al.  The RASSF proteins in cancer; from epigenetic silencing to functional characterization. , 2009, Biochimica et biophysica acta.

[10]  Liang Qiao,et al.  Bistability and Oscillations in the Huang-Ferrell Model of MAPK Signaling , 2007, PLoS Comput. Biol..

[11]  J. Avruch,et al.  Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. , 2004, The Biochemical journal.

[12]  Walter Kolch,et al.  RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. , 2007, Molecular cell.

[13]  J E Ferrell,et al.  The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. , 1998, Science.

[14]  J. Small,et al.  Raf-1 regulates Rho signaling and cell migration , 2005, The Journal of cell biology.

[15]  G. Rodan,et al.  Mapping of MST1 Kinase Sites of Phosphorylation , 2002, The Journal of Biological Chemistry.

[16]  M. Wigler,et al.  Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.

[17]  Dirk Roose,et al.  Numerical modelling of label-structured cell population growth using CFSE distribution data , 2007, Theoretical Biology and Medical Modelling.

[18]  Michael J Ackerman,et al.  Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy , 2007, Nature Genetics.

[19]  G. Halder,et al.  An evolutionary shift in the regulation of the Hippo pathway between mice and flies , 2014, Oncogene.

[20]  G. Halder,et al.  Hippo signaling: growth control and beyond , 2011, Development.

[21]  G. Hammes,et al.  A kinetic study of protein-protein interactions. , 1976, Biochemistry.

[22]  B. Link,et al.  Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway , 2014, Mechanisms of Development.

[23]  W. Kolch,et al.  Regulation of Raf‐1 activation and signalling by dephosphorylation , 2002, The EMBO journal.

[24]  E. Gilles,et al.  Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors , 2002, Nature Biotechnology.

[25]  J. Hancock,et al.  Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions , 2001, Oncogene.

[26]  Michiko Furutani,et al.  Germline gain-of-function mutations in RAF1 cause Noonan syndrome , 2007, Nature Genetics.

[27]  Rey-Huei Chen,et al.  Molecular interpretation of ERK signal duration by immediate early gene products , 2002, Nature Cell Biology.

[28]  G. Pfeifer,et al.  The Tumor Suppressor RASSF1A Prevents Dephosphorylation of the Mammalian STE20-like Kinases MST1 and MST2* , 2011, The Journal of Biological Chemistry.

[29]  M. Pacher,et al.  Dephosphorylation of Ser-259 Regulates Raf-1 Membrane Association* , 2002, The Journal of Biological Chemistry.

[30]  A. Mauk,et al.  Reduction of horse heart ferricytochrome c by bovine liver ferrocytochrome b5. Experimental and theoretical analysis. , 1991, Biochemistry.

[31]  T. Höfer,et al.  Competition Effects Shape the Response Sensitivity and Kinetics of Phosphorylation Cycles in Cell Signaling , 2006, Annals of the New York Academy of Sciences.

[32]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[33]  Boris N. Kholodenko,et al.  Signalling ballet in space and time , 2010, Nature Reviews Molecular Cell Biology.

[34]  P. Güntert,et al.  Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway , 2007, Proceedings of the National Academy of Sciences.

[35]  Walter Kolch,et al.  Role of the Kinase MST2 in Suppression of Apoptosis by the Proto-Oncogene Product Raf-1 , 2004, Science.

[36]  M. Mann,et al.  Comparative Proteomic Analysis of Eleven Common Cell Lines Reveals Ubiquitous but Varying Expression of Most Proteins* , 2012, Molecular & Cellular Proteomics.

[37]  M. Barbacid,et al.  Mutant K-Ras activation of the proapoptotic MST2 pathway is antagonized by wild-type K-Ras. , 2011, Molecular cell.

[38]  W. Kolch,et al.  Raf family kinases: old dogs have learned new tricks. , 2011, Genes & cancer.

[39]  N. Dumaz,et al.  Protein Kinase A Blocks Raf-1 Activity by Stimulating 14-3-3 Binding and Blocking Raf-1 Interaction with Ras* , 2003, Journal of Biological Chemistry.

[40]  B. Kholodenko.  Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.

[41]  Fan Mou,et al.  Protein kinases of the Hippo pathway: regulation and substrates. , 2012, Seminars in cell & developmental biology.

[42]  John J. Tyson,et al.  Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[43]  P. Warne,et al.  Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.

[44]  W. Kolch,et al.  Cyclic AMP-Dependent Kinase Regulates Raf-1 Kinase Mainly by Phosphorylation of Serine 259 , 2002, Molecular and Cellular Biology.

[45]  Walter Kolch,et al.  Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt. , 2010, Cancer research.

[46]  G. Pfeifer,et al.  RASSF1A Is Part of a Complex Similar to the Drosophila Hippo/Salvador/Lats Tumor-Suppressor Network , 2007, Current Biology.

[47]  Giulio Superti‐Furga,et al.  Serine and tyrosine phosphorylations cooperate in Raf‐1, but not B‐Raf activation , 1999, The EMBO journal.

[48]  E. O’Neill,et al.  ATM Regulates a RASSF1A-Dependent DNA Damage Response , 2009, Current Biology.

[49]  Walter Kolch,et al.  Cell fate decisions are specified by the dynamic ERK interactome , 2009, Nature Cell Biology.

[50]  B. Kholodenko,et al.  Signaling switches and bistability arising from multisite phosphorylation in protein kinase cascades , 2004, The Journal of cell biology.

[51]  M. Cobb,et al.  Signal control through Raf: in sickness and in health , 2011, Cell Research.

[52]  Ronen Marmorstein,et al.  Biochemical analysis of MST1 kinase: elucidation of a C-terminal regulatory region. , 2008, Biochemistry.

[53]  Ming Zhou,et al.  Regulation of Raf-1 by direct feedback phosphorylation. , 2005, Molecular cell.

[54]  E. Nigg,et al.  The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 , 2005, Oncogene.

[55]  Boris N. Kholodenko,et al.  Ligand-Specific c-Fos Expression Emerges from the Spatiotemporal Control of ErbB Network Dynamics , 2010, Cell.

[56]  D. Morrison,et al.  Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro , 1995, Molecular and cellular biology.

[57]  Mengwei Zang,et al.  Phosphorylation of 338SSYY341 Regulates Specific Interaction between Raf-1 and MEK1* , 2002, The Journal of Biological Chemistry.

[58]  J. Avruch,et al.  The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1 , 2002, Oncogene.

[59]  Muffy Calder,et al.  The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier , 2010, Science Signaling.

[60]  Walter Kolch,et al.  Phosphatase and Feedback Regulation of Raf-1 Signaling , 2007, Cell cycle.

[61]  Xiaolong Yang,et al.  LATS tumor suppressor: A new governor of cellular homeostasis , 2010, Cell cycle.

[62]  H. Erickson,et al.  Kinetics of protein-protein association explained by Brownian dynamics computer simulation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Xavier,et al.  Rassf Family of Tumor Suppressor Polypeptides* , 2009, Journal of Biological Chemistry.

[64]  James E. Ferrell,et al.  Substrate Competition as a Source of Ultrasensitivity in the Inactivation of Wee1 , 2007, Cell.